Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Endocrine Disorders
Published in: BMC Endocrine Disorders 1/2023

Open Access 01-12-2023 | Obesity | Research

The interaction between CRY1 Polymorphism and Alternative Healthy Eating Index (AHEI) on cardiovascular risk factors in overweight women and women with obesity: a cross-sectional study

Authors: Fatemeh Dehghani Firouzabadi, Atieh Mirzababaei, Farideh Shiraseb, Hadith Tangestani, Khadijeh Mirzaei

Published in: BMC Endocrine Disorders | Issue 1/2023

Login to get access

Abstract

Background

According to some studies, diet can be interaction with CRY1 polymorphism and may be related to obesity and the risk of cardiovascular diseases (CVD). So, this study examined the interaction between CRY1 polymorphism and AHEI on cardiovascular risk factors in overweight women and women with obesity.

Methods

This cross-sectional study was performed on 377 Iranian women with overweight and obesity aged 18–48(BMI ≥ 25 kg/m2). Dietary intake was evaluated by the use of a food frequency questionnaire (FFQ) with 147 items. The AHEI was calculated based on previous studies. Anthropometric and biochemical measurements were assessed and the bioelectrical impedance analysis method was used for body analysis. The rs2287161 was genotyped by the restriction fragment length polymorphism (PCR-RFLP) method. Objects were divided into three groups based on rs2287161 genotypes.

Results

Our findings determined that the prevalence of the C allele was 51.9% and the G allele was 48.0%. The mean age and BMI were 36.6 ± 9.1years and 31 ± 4 kg/m2 respectively. After controlling for confounders (BMI, age, total energy intake, and physical activity), this study demonstrated that there was a significant interaction between CC genotype and adherence to AHEI on odds of hyper LDL (OR = 1.94, 95% CI = 1.24–3.05, P for interaction = 0.004), hypertension (OR = 1.80, 95% CI = 1.11–2.93, P for interaction = 0.01) and hyperglycemia (OR = 1.56, 95% CI = 0.98–2.47, P for interaction = 0.05).

Conclusions

This study indicated that adherence to AHEI can reduce the odds of hyper LDL, hypertension, and hyperglycemia in the CC genotype of rs2287161.
Literature
1.
2.
Ayatollahi S, Ghoreshizadeh Z. Prevalence of obesity and overweight among adults in Iran. Obes Rev. 2010;11(5):335–7.PubMed
3.
Jafari-Adli S, Jouyandeh Z, Qorbani M, Soroush A, Larijani B, Hasani-Ranjbar S. Prevalence of obesity and overweight in adults and children in Iran; a systematic review. J Diabetes Metabolic Disorders. 2014;13(1):121.
4.
Collaboration NRF. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19· 2 million participants. The Lancet. 2016;387(10026):1377–96.
5.
King SE, Skinner MK. Epigenetic transgenerational inheritance of obesity susceptibility. Trends Endocrinol Metab. 2020;31(7):478–94.PubMedPubMedCentral
6.
Ahmad NN, Butsch WS, Aidarous S. Clinical management of obesity in women: addressing a lifecycle of risk. Obstet Gynecol Clin. 2016;43(2):201–30.
7.
Tørris C, Bjørnnes AK. Duration of Lactation and maternal risk of metabolic syndrome: a systematic review and Meta-analysis. Nutrients. 2020;12(9):2718.PubMedPubMedCentral
8.
Shahid SU, Sarwar S. The abnormal lipid profile in obesity and coronary heart disease (CHD) in pakistani subjects. Lipids Health Dis. 2020;19:1–7.
9.
Ballotari P, Venturelli F, Greci M, Giorgi Rossi P, Manicardi V. Sex differences in the effect of type 2 diabetes on major cardiovascular diseases: results from a population-based study in Italy. International J endocrinology 2017, 2017.
10.
Yu E, Malik VS, Hu FB. Cardiovascular disease prevention by diet modification: JACC health promotion series. J Am Coll Cardiol. 2018;72(8):914–26.PubMedPubMedCentral
11.
Hruby A, Manson JE, Qi L, Malik VS, Rimm EB, Sun Q, Willett WC, Hu FB. Determinants and consequences of obesity. Am J Public Health. 2016;106(9):1656–62.PubMedPubMedCentral
12.
Fardet A, Rock E. Toward a new philosophy of preventive nutrition: from a reductionist to a holistic paradigm to improve nutritional recommendations. Adv Nutr. 2014;5(4):430–46.PubMedPubMedCentral
13.
Chiuve SE, Fung TT, Rimm EB, Hu FB, McCullough ML, Wang M, Stampfer MJ, Willett WC. Alternative dietary indices both strongly predict risk of chronic disease. J Nutr. 2012;142(6):1009–18.PubMedPubMedCentral
14.
Onvani S, Haghighatdoost F, Surkan P, Larijani B, Azadbakht L. Adherence to the healthy eating Index and Alternative Healthy Eating Index dietary patterns and mortality from all causes, cardiovascular disease and cancer: a meta-analysis of observational studies. J Hum Nutr Dietetics. 2017;30(2):216–26.
15.
Khodarahmi M, Asghari-Jafarabadi M, Abbasalizad Farhangi M. A structural equation modeling approach for the association of a healthy eating index with metabolic syndrome and cardio-metabolic risk factors among obese individuals. PLoS ONE. 2019;14(7):e0219193.PubMedPubMedCentral
16.
Schwingshackl L, Hoffmann G. Diet quality as assessed by the healthy eating Index, the alternate healthy eating Index, the Dietary Approaches to stop hypertension score, and health outcomes: a systematic review and meta-analysis of cohort studies. J Acad Nutr Dietetics. 2015;115(5):780–800. e785.
17.
Wu PY, Huang CL, Lei WS, Yang SH. Alternative health eating index and the D ietary G uidelines from a merican D iabetes a ssociation both may reduce the risk of cardiovascular disease in type 2 diabetes patients. J Hum Nutr Dietetics. 2016;29(3):363–73.
18.
Gasmi A, et al. Obesity and insulin resistance: associations with chronic inflammation, genetic and epigenetic factors. Curr Med Chem. 2021;28(4):800–26.PubMed
19.
Garaulet M, Madrid JA. Chronobiology, genetics and metabolic syndrome. Curr Opin Lipidol. 2009;20(2):127–34.PubMed
20.
Ye D, Cai S, Jiang X, Ding Y, Chen K, Fan C, Jin M. Associations of polymorphisms in circadian genes with abdominal obesity in chinese adult population. Obes Res Clin Pract. 2016;10:133–S141.
21.
Lemmer B, Oster H. The role of circadian rhythms in the hypertension of diabetes mellitus and the metabolic syndrome. Curr Hypertens Rep. 2018;20(5):43.PubMed
22.
Kovanen L, Donner K, Kaunisto M, Partonen T. CRY1, CRY2 and PRKCDBP genetic variants in metabolic syndrome. Hypertens Res. 2015;38(3):186–92.PubMed
23.
Gomez-Abellan P, Hernandez-Morante J, Lujan J, Madrid J, Garaulet M. Clock genes are implicated in the human metabolic syndrome. Int J Obes. 2008;32(1):121–8.
24.
Dashti HS, Smith CE, Lee Y-C, Parnell LD, Lai C-Q, Arnett DK, Ordovás JM, Garaulet M. CRY1 circadian gene variant interacts with carbohydrate intake for insulin resistance in two independent populations: Mediterranean and North American. Chronobiol Int. 2014;31(5):660–7.PubMedPubMedCentral
25.
Tamtaji OR, Borzabadi S, Ghayour-Mobarhan M, Ferns G, Asemi Z. The effects of fatty acids consumption on OPG/RANKL/RANK system in cardiovascular diseases: current status and future perspectives for the impact of diet‐gene interaction. J Cell Biochem. 2019;120(3):2774–81.PubMed
26.
Albuquerque D, Nóbrega C, Manco L, Padez C. The contribution of genetics and environment to obesity. Br Med Bull. 2017;123(1):159–73.PubMed
27.
Engin A. Circadian rhythms in diet-induced obesity. Obesity and lipotoxicity. edn.: Springer; 2017: 19–52.
28.
Sherman H, Genzer Y, Cohen R, Chapnik N, Madar Z, Froy O. Timed high-fat diet resets circadian metabolism and prevents obesity. FASEB J. 2012;26(8):3493–502.PubMed
29.
Okamura H, Doi M, Goto K, Kojima R. Clock genes and salt-sensitive hypertension: a new type of aldosterone-synthesizing enzyme controlled by the circadian clock and angiotensin II. Hypertens Res. 2016;39(10):681–7.PubMed
30.
Oishi K, Uchida D, Itoh N. Low-carbohydrate, high-protein diet affects rhythmic expression of gluconeogenic regulatory and circadian clock genes in mouse peripheral tissues. Chronobiol Int. 2012;29(7):799–809.PubMed
31.
Griebel G, Ravinet-Trillou C, Beeské S, Avenet P, Pichat P. Mice deficient in cryptochrome 1 (Cry1–/–) exhibit resistance to obesity induced by a high-fat diet. Front Endocrinol. 2014;5:49.
32.
Hu EA, Steffen LM, Coresh J, Appel LJ, Rebholz CM. Adherence to the healthy eating Index–2015 and other dietary patterns may reduce risk of Cardiovascular Disease, Cardiovascular Mortality, and all-cause mortality. J Nutr. 2020;150(2):312–21.PubMed
33.
Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381–95.PubMed
34.
Ainsworth BE, Haskell WL, Herrmann SD, Meckes N, Bassett DR Jr, Tudor-Locke C, Greer JL, Vezina J, Whitt-Glover MC, Leon AS. 2011 Compendium of Physical Activities: a second update of codes and MET values. Med Sci Sports Exerc. 2011;43(8):1575–81.PubMed
35.
Mirmiran P, Esfahani FH, Mehrabi Y, Hedayati M, Azizi F. Reliability and relative validity of an FFQ for nutrients in the Tehran lipid and glucose study. Public Health Nutr. 2010;13(5):654–62.PubMed
36.
Hosseini-Esfahani F, Jessri M, Mirmiran P, Bastan S, Azizi F. Adherence to dietary recommendations and risk of metabolic syndrome: Tehran lipid and glucose study. Metabolism. 2010;59(12):1833–42.PubMed
37.
Mirzababaei A, Sajjadi SF, Ghodoosi N, Pooyan S, Arghavani H, Yekaninejad MS, Mirzaei K. Relations of major dietary patterns and metabolically unhealthy overweight/obesity phenotypes among iranian women. Diabetes & metabolic syndrome. 2019;13(1):322–31.
38.
Alberti K, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart J-C, James WPT, Loria CM, Smith SC Jr. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; american heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation. 2009;120(16):1640–5.PubMed
39.
Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9.PubMed
40.
Abaj F, Koohdani F, Rafiee M, Alvandi E, Yekaninejad MS, Mirzaei K. Interactions between Caveolin-1 (rs3807992) polymorphism and major dietary patterns on cardio-metabolic risk factors among obese and overweight women. BMC Endocr disorders. 2021;21(1):138.
41.
Doi M, Takahashi Y, Komatsu R, Yamazaki F, Yamada H, Haraguchi S, Emoto N, Okuno Y, Tsujimoto G, Kanematsu A. Salt-sensitive hypertension in circadian clock–deficient Cry-null mice involves dysregulated adrenal Hsd3b6. Nat Med. 2010;16(1):67.PubMed
42.
Tahira K, Ueno T, Fukuda N, Aoyama T, Tsunemi A, Matsumoto S, Nagura C, Matsumoto T, Soma M, Shimba S. Obesity alters the expression profile of clock genes in peripheral blood mononuclear cells. Archives of medical science: AMS. 2011;7(6):933.PubMedPubMedCentral
43.
Ikeda H, Yong Q, Kurose T, Todo T, Mizunoya W, Fushiki T, Seino Y, Yamada Y. Clock gene defect disrupts light-dependency of autonomic nerve activity. Biochem Biophys Res Commun. 2007;364(3):457–63.PubMed
44.
Consortium I. Adherence to predefined dietary patterns and incident type 2 diabetes in european populations: EPIC-InterAct study. Diabetologia. 2014;57(2):321–33.
45.
Saraf-Bank S, Haghighatdoost F, Esmaillzadeh A, Larijani B, Azadbakht L. Adherence to healthy eating Index-2010 is inversely associated with metabolic syndrome and its features among iranian adult women. Eur J Clin Nutr. 2017;71(3):425–30.PubMed
46.
Barclay JL, Shostak A, Leliavski A, Tsang AH, Jöhren O, Müller-Fielitz H, Landgraf D, Naujokat N, van der Horst GT, Oster H. High-fat diet-induced hyperinsulinemia and tissue-specific insulin resistance in Cry-deficient mice. Am J Physiol Endocrinol metabolism. 2013;304(10):E1053–1063.
47.
Lamia KA, Papp SJ, Ruth TY, Barish GD, Uhlenhaut NH, Jonker JW, Downes M, Evans RM. Cryptochromes mediate rhythmic repression of the glucocorticoid receptor. Nature. 2011;480(7378):552–6.PubMedPubMedCentral
48.
Prasath GS, Pillai SI, Subramanian SP. Fisetin improves glucose homeostasis through the inhibition of gluconeogenic enzymes in hepatic tissues of streptozotocin induced diabetic rats. Eur J Pharmacol. 2014;740:248–54.PubMed
49.
Nicolle C, Cardinault N, Gueux E, Jaffrelo L, Rock E, Mazur A, Amouroux P, Rémésy C. Health effect of vegetable-based diet: lettuce consumption improves cholesterol metabolism and antioxidant status in the rat. Clin Nutr. 2004;23(4):605–14.PubMed
50.
Müllner E, Plasser E, Brath H, Waldschütz W, Forster E, Kundi M, Wagner KH. Impact of polyunsaturated vegetable oils on adiponectin levels, glycaemia and blood lipids in individuals with type 2 diabetes: a randomised, double-blind intervention study. J Hum Nutr dietetics. 2014;27(5):468–78.
51.
Feng S, Belwal T, Li L, Limwachiranon J, Liu X, Luo Z. Phytosterols and their derivatives: potential health-promoting uses against lipid metabolism and associated diseases, mechanism, and safety issues. Compr Rev Food Sci Food Saf. 2020;19(4):1243–67.PubMed
Metadata
Title
The interaction between CRY1 Polymorphism and Alternative Healthy Eating Index (AHEI) on cardiovascular risk factors in overweight women and women with obesity: a cross-sectional study
Authors
Fatemeh Dehghani Firouzabadi
Atieh Mirzababaei
Farideh Shiraseb
Hadith Tangestani
Khadijeh Mirzaei
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2023
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-023-01429-9

Other articles of this Issue 1/2023

BMC Endocrine Disorders 1/2023 Go to the issue

Research

Triglyceride-glucose index and cervical vascular function: outpatient-based cohort study

Case report

A case of Marine Lenhart syndrome with Hashimoto’s thyroiditis that mimicked thyroid carcinoma

Research

Prevalence of anemia and its associated factors among patients with type 2 diabetes mellitus in a referral diabetic clinic in the north of Iran

Research

Association between a high triglyceride–glucose index and chronic kidney disease in adult patients with latent autoimmune diabetes

Case report

Central diabetes insipidus: a late sequela of BNT162b2 SARS-CoV-2 mRNA vaccine?

Research

Effects of probiotic/synbiotic supplementation on body weight in patients with diabetes: a systematic review and meta-analyses of randomized-controlled trials
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits